UnlockRegeneron flags $56M R&D charge in Q3 financials
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Regeneron Pharmaceuticals Inc (REGN)
996.05
-16.77(-1.66%)
Closed
After Hours
995.47-0.58(-0.06%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
992.80
1,011.70
52 wk Range
769.19
1,211.20
REGN Scorecard
Full Analysis
Management has been aggressively buying back shares
Regeneron Pharmaceuticals Inc stock price live, this page displays NASDAQ REGN stock exchange data. View the REGN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Regeneron Pharmaceuticals Inc real time stock price chart below.
What Is the Regeneron Pharmaceuticals Inc Stock Price Today?
The Regeneron Pharmaceuticals Inc stock price today is 996.05.
From a Technical Analysis Perspective, Is REGN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is %TECH_ANALYSIS_BUY_SELL_DAILY%. %TECH_ANALYSIS_BUY_SELL%
What Is the Stock Symbol for Regeneron Pharmaceuticals Inc?
The stock symbol for Regeneron Pharmaceuticals Inc is ""REGN.""
What Stock Exchange Does Regeneron Pharmaceuticals Inc Trade On?
Regeneron Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Regeneron Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Regeneron Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the REGN quote. (ISIN: US75886F1075)
What Is the Regeneron Pharmaceuticals Inc Stock Price Today?
The Regeneron Pharmaceuticals Inc stock price today is 996.05.
From a Technical Analysis Perspective, Is REGN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is %TECH_ANALYSIS_BUY_SELL_DAILY%. %TECH_ANALYSIS_BUY_SELL%
What Is the Stock Symbol for Regeneron Pharmaceuticals Inc?
The stock symbol for Regeneron Pharmaceuticals Inc is ""REGN.""
What Stock Exchange Does Regeneron Pharmaceuticals Inc Trade On?
Regeneron Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Regeneron Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Regeneron Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the REGN quote. (ISIN: US75886F1075)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
992.801,011.70
52 wk Range
769.191,211.20
REGN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
1,158.07
Upside
+16.27%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Regeneron Phar. receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Regeneron flags $56M R&D charge in Q3 financials
- Investing.com
- BMO maintains Outperform rating on Regeneron shares
- Investing.com
- Regeneron Phar. receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Regeneron Pharmaceuticals Inc Company Profile
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types; and with Sonoma Biotherapeutics, Inc. to discover, develop, and commercialize engineered regulatory T cell therapies. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
Compare REGN to Peers and Sector
Metrics to compare | REGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipREGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 24.9x | −0.9x | −0.6x | |
PEG Ratio | - | −0.01 | 0.00 | |
Price/Book | 3.8x | 0.1x | 2.6x | |
Price / LTM Sales | 8.0x | 1.4x | 3.2x | |
Upside (Analyst Target) | 19.5% | 5,080.3% | 44.4% | |
Fair Value Upside | Unlock | 8.1% | 6.2% | Unlock |
People Also Watch
FAQ
What Is the Regeneron Pharma (REGN) Stock Price Today?
The Regeneron Pharma (REGN) stock price today is 996.05. Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Regeneron Pharma Trade On?
Regeneron Pharma is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Regeneron Pharma?
The stock symbol for Regeneron Pharma is "REGN."
What Is the Regeneron Pharma Market Cap?
As of today, Regeneron Pharma market cap is 107.43B.
What is Regeneron Pharma Earnings Per Share?
The Regeneron Pharma EPS is 40.31.
What Is the Next Regeneron Pharma Earnings Date?
Regeneron Pharma will release its next earnings report on 30 Oct 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.